Month: June 2022

RT @ModernRetina: The U.S. Centers for Medicare and Medicaid Services code is ef…

RT @ModernRetina: The U.S. Centers for Medicare and Medicaid Services code is effective July 1 and will enhance access to Xipere, the only… Source by Thomas Ciulla, MD, MBA Return to main website.

Looking forward to discussing drug delivery and durability at OIS ASRS! …

Looking forward to discussing drug delivery and durability at OIS ASRS! https://t.co/hOsw51ABAd Source by Thomas Ciulla, MD, MBA Return to main website.

Suprachoroidal triamcinolone acetonide injectable suspension for macular edema a…


Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with uveitis: Effect of disease characteristics on clinical outcomes | IOVS | ARVO Journals https://t.co/UgGLPY5nln


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @OphthTimes: @BauschLomb annonced today it has received a permanent J-Code fo…

RT @OphthTimes: @BauschLomb annonced today it has received a permanent J-Code for triamcinolone acetonide injectable suspension (Xipere). #… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: “Longer-Term Anti-VEGF Therapy Outcomes in …

RT @ThomasCiullaMD: Just published: https://t.co/iavHrQFgR9 “Longer-Term Anti-VEGF Therapy Outcomes in Neovascular #AMD, #DME, and RVO Macu… Source by Thomas Ciulla, MD, MBA Return to main website.

Age adjusted differences in vascular and metabolic biomarkers between patients w…


Age adjusted differences in vascular and metabolic biomarkers between patients with open-glaucoma and healthy controls | IOVS | ARVO Journals https://t.co/EeqmtDgS6e


Source by Thomas Ciulla, MD, MBA

Return to main website.

Suprachoroidal triamcinolone acetonide injectable suspension for macular edema a…

Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with uveitis: Integrated analysis of two clinical trials | IOVS | ARVO Journals https://t.co/bMb8UImn5o Source by Thomas Ciulla, MD, MBA Return to main website.

Targeting, Compartmentalization and Durability of Suprachoroidally Injected Smal…

Targeting, Compartmentalization and Durability of Suprachoroidally Injected Small Molecule Suspensions in Multiple Preclinical Models | IOVS | ARVO Journals https://t.co/b1Rof8D9aD Source by Thomas Ciulla, MD, MBA Return to main website.

National physician survey on clinical practice patterns for the treatment of non…


National physician survey on clinical practice patterns for the treatment of noninfectious uveitis | IOVS | ARVO Journals https://t.co/UMNEwjPTjd


Source by Thomas Ciulla, MD, MBA

Return to main website.

Honored to present at the Macula Society Annual Meeting today! #eyes #retina #m…

Honored to present at the Macula Society Annual Meeting today! #eyes #retina #macula #maculardegeneration #AMD #ophthalmology #clinicalresearch https://t.co/mrUMR1zRsG Source by Thomas Ciulla, MD, MBA Return to main website.